291 related articles for article (PubMed ID: 29750331)
1. Salivary-gland-protective regulatory T-cell dysfunction underlies female-specific sialadenitis in the non-obese diabetic mouse model of Sjögren syndrome.
Barr JY; Wang X; Kreiger PA; Lieberman SM
Immunology; 2018 Oct; 155(2):225-237. PubMed ID: 29750331
[TBL] [Abstract][Full Text] [Related]
2. Reversible lacrimal gland-protective regulatory T-cell dysfunction underlies male-specific autoimmune dacryoadenitis in the non-obese diabetic mouse model of Sjögren syndrome.
Lieberman SM; Kreiger PA; Koretzky GA
Immunology; 2015 Jun; 145(2):232-41. PubMed ID: 25581706
[TBL] [Abstract][Full Text] [Related]
3. Suppression of age-related salivary gland autoimmunity by glycosylation-dependent galectin-1-driven immune inhibitory circuits.
Martínez Allo VC; Hauk V; Sarbia N; Pinto NA; Croci DO; Dalotto-Moreno T; Morales RM; Gatto SG; Manselle Cocco MN; Stupirski JC; Deladoey Á; Maronna E; Marcaida P; Durigan V; Secco A; Mamani M; Dos Santos A; Catalán Pellet A; Pérez Leiros C; Rabinovich GA; Toscano MA
Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6630-6639. PubMed ID: 32161138
[TBL] [Abstract][Full Text] [Related]
4. CD8 T cells contribute to lacrimal gland pathology in the nonobese diabetic mouse model of Sjögren syndrome.
Barr JY; Wang X; Meyerholz DK; Lieberman SM
Immunol Cell Biol; 2017 Sep; 95(8):684-694. PubMed ID: 28465508
[TBL] [Abstract][Full Text] [Related]
5. Type I Interferon Signaling Is Required for Dacryoadenitis in the Nonobese Diabetic Mouse Model of Sjögren Syndrome.
Chaly Y; Barr JY; Sullivan DA; Thomas HE; Brodnicki TC; Lieberman SM
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347820
[TBL] [Abstract][Full Text] [Related]
6. Agonist-induced 4-1BB activation prevents the development of Sjӧgren's syndrome-like sialadenitis in non-obese diabetic mice.
Zhou J; You BR; Yu Q
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165605. PubMed ID: 31740402
[TBL] [Abstract][Full Text] [Related]
7. Smad4 in T cells plays a protective role in the development of autoimmune Sjögren's syndrome in the nonobese diabetic mouse.
Kim D; Kim JY; Jun HS
Oncotarget; 2016 Dec; 7(49):80298-80312. PubMed ID: 27880731
[TBL] [Abstract][Full Text] [Related]
8. E2F-1-deficient NOD/SCID mice developed showing decreased saliva production.
Matsui-Inohara H; Uematsu H; Narita T; Satoh K; Yonezawa H; Kuroda K; Ito T; Yoneda S; Kawarai T; Sugiya H; Watanabe H; Senpuku H
Exp Biol Med (Maywood); 2009 Dec; 234(12):1525-36. PubMed ID: 19934373
[TBL] [Abstract][Full Text] [Related]
9. Correction of autophagy impairment inhibits pathology in the NOD.H-2h4 mouse model of primary Sjögren's syndrome.
Voynova E; Lefebvre F; Qadri A; Muller S
J Autoimmun; 2020 Mar; 108():102418. PubMed ID: 32029330
[TBL] [Abstract][Full Text] [Related]
10. Reciprocal relation between GADD153 and Del-1 in regulation of salivary gland inflammation in Sjögren syndrome.
Baban B; Liu JY; Abdelsayed R; Mozaffari MS
Exp Mol Pathol; 2013 Dec; 95(3):288-97. PubMed ID: 24060278
[TBL] [Abstract][Full Text] [Related]
11. B7-H4 Inhibits the Development of Primary Sjögren's Syndrome by Regulating Treg Differentiation in NOD/Ltj Mice.
Zheng X; Wang Q; Yuan X; Zhou Y; Chu H; Wang G; Li X; Wang Y; Wei L; Wang L; Li X
J Immunol Res; 2020; 2020():4896727. PubMed ID: 33062721
[TBL] [Abstract][Full Text] [Related]
12. Local delivery of AAV2-CTLA4IgG decreases sialadenitis and improves gland function in the C57BL/6.NOD-Aec1Aec2 mouse model of Sjögren's syndrome.
Yin H; Nguyen CQ; Samuni Y; Uede T; Peck AB; Chiorini JA
Arthritis Res Ther; 2012 Feb; 14(1):R40. PubMed ID: 22369699
[TBL] [Abstract][Full Text] [Related]
13. Non-depleting anti-CD4 antibody not only prevents onset but resolves sialadenitis in NOD mice.
Thompson C; Jacobsen H; Pomeranz Krummel D; Nagai K; Cooke A
Autoimmunity; 2004 Dec; 37(8):549-54. PubMed ID: 15763917
[TBL] [Abstract][Full Text] [Related]
14. Plasmacytoid dendritic cells promote the pathogenesis of Sjögren's syndrome.
Zhou J; Zhang X; Yu Q
Biochim Biophys Acta Mol Basis Dis; 2022 Feb; 1868(2):166302. PubMed ID: 34780913
[TBL] [Abstract][Full Text] [Related]
15. Metformin improves salivary gland inflammation and hypofunction in murine Sjögren's syndrome.
Kim JW; Kim SM; Park JS; Hwang SH; Choi J; Jung KA; Ryu JG; Lee SY; Kwok SK; Cho ML; Park SH
Arthritis Res Ther; 2019 Jun; 21(1):136. PubMed ID: 31164166
[TBL] [Abstract][Full Text] [Related]
16. Transient depletion of CD4+ CD25+ regulatory T cells results in multiple autoimmune diseases in wild-type and B-cell-deficient NOD mice.
Ellis JS; Wan X; Braley-Mullen H
Immunology; 2013 Jun; 139(2):179-86. PubMed ID: 23293979
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic role of endogenous TNF-α in the development of Sjögren's-like sialadenitis and secretory dysfunction in non-obese diabetic mice.
Zhou J; Kawai T; Yu Q
Lab Invest; 2017 Apr; 97(4):458-467. PubMed ID: 28067896
[TBL] [Abstract][Full Text] [Related]
18. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
[TBL] [Abstract][Full Text] [Related]
19. Different lymphoproliferative disorders in different salivary glands of primary Sjögren syndrome.
Zheng L; Yu C; Yang C
J Craniofac Surg; 2013; 24(5):e462-5. PubMed ID: 24036814
[TBL] [Abstract][Full Text] [Related]
20. Sex differences in a murine model of Sjögren's syndrome.
Ciháková D; Talor MV; Barin JG; Baldeviano GC; Fairweather D; Rose NR; Burek CL
Ann N Y Acad Sci; 2009 Sep; 1173():378-83. PubMed ID: 19758176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
